Decline in the Market Value of Shares Held and Deterioration in the Creditworthiness of Investee Companies
First written in FY2016. 11 of 24 entries say "Mitigated", first in FY2022-Q2. Latest entry: 2026-11-11.
The whole theme swung hardest in 2019: 43 of 85 companies on the "Worse" side.
29 other companies' latest entry also says "Mitigated".
- FY2026MaterialisedAnnual report
「This was mainly due to increases of ¥666 million in retained earnings and ¥60 million in treasury shares, and a ¥110 million decrease in the valuation difference on available-for-sale securities.」
The valuation difference on available-for-sale securities decreased by ¥110.566 million, with changes in the fair value of held shares and other assets appearing as an actual factor behind the decline in net assets. - FY2026-H1MaterialisedAnnual report
「This was mainly due to increases of ¥428 million in retained earnings and ¥68 million in treasury shares, and decreases of ¥158 million in the valuation difference on available-for-sale securities and ¥43 million in the foreign currency translation adjustment account.」
The valuation difference on available-for-sale securities decreased by ¥158 million, with changes in the valuation of held shares and other assets appearing as an actual factor behind the decline in net assets. - FY2025MaterialisedAnnual report
「This was mainly due to decreases of ¥933 million in retained earnings and ¥207 million in the valuation difference on available-for-sale securities, and a ¥339 million increase in treasury shares.」
The valuation difference on available-for-sale securities decreased by ¥207 million, with changes in the fair value of held shares and other assets appearing as an actual factor behind the decline in net assets. - FY2025-H1MitigatedAnnual report
「This was due mainly to increases of ¥149 million in the valuation difference on available-for-sale securities and ¥73 million in retained earnings.」
The valuation difference on available-for-sale securities increased by ¥149 million, reducing during the interim period the adverse impact on net assets from changes in the valuation of held shares and other assets. - FY2024MaterialisedAnnual report
「During the current consolidated fiscal year, the Company recognized an impairment loss of ¥212 thousand on shares classified as other securities.」
The impairment risk arising from declines in the fair value of held shares and deterioration in creditworthiness materialized as a ¥212 thousand loss on valuation of investment securities. - FY2024-Q3MitigatedAnnual report
「Total net assets increased by ¥645 million from the end of the previous consolidated fiscal year to ¥9.96 billion. This was mainly due to increases of ¥468 million in the valuation difference on available-for-sale securities and ¥129 million in retained earnings.」
The valuation difference on available-for-sale securities increased by ¥468 million, mitigating during the cumulative third quarter period the adverse impact on net assets from the decline in the valuation difference through the previous fiscal year. - FY2024-Q2MitigatedAnnual report
「Total net assets increased by ¥445 million from the end of the previous consolidated fiscal year to ¥9.76 billion. This was mainly due to increases of ¥344 million in the valuation difference on available-for-sale securities, ¥54 million in retained earnings, and ¥49 million in the foreign currency translation adjustment account.」
The valuation difference on available-for-sale securities increased by ¥344 million, with the valuation difference on held shares and other assets, which had declined significantly in the previous fiscal year, moving toward recovery. - FY2024-Q1MitigatedAnnual report
「This was mainly due to a ¥194 million increase in the valuation difference on available-for-sale securities.」
The valuation difference on available-for-sale securities increased by ¥194 million, with the adverse impact on net assets from changes in the valuation of held shares and other assets moving toward recovery during the current quarter. - FY2023MitigatedAnnual report
「This was mainly due to increases of ¥187 million in retained earnings, ¥68 million in the valuation difference on available-for-sale securities, and ¥53 million in the foreign currency translation adjustment account.」
The valuation difference on available-for-sale securities turned to an increase of ¥68 million after the significant decline in the previous fiscal year, reducing the adverse impact on net assets from changes in the valuation of held shares and other assets. - FY2023-Q3MitigatedAnnual report
「Valuation difference on available-for-sale securities ¥906,477 ¥926,463」
The valuation difference on available-for-sale securities increased by approximately ¥20 million from the end of the previous consolidated fiscal year, moving toward recovery after the significant decline in the previous fiscal year. - FY2023-Q2MitigatedAnnual report
「Total net assets increased by ¥236 million from the end of the previous consolidated fiscal year to ¥9.247 billion. This was mainly due to increases of ¥80 million in the valuation difference on available-for-sale securities, ¥79 million in retained earnings, and ¥79 million in the foreign currency translation adjustment account.」
The valuation difference on available-for-sale securities increased by ¥80 million, with the valuation difference that had declined significantly in the previous fiscal year moving toward recovery in the second quarter of the current fiscal year. - FY2023-Q1MitigatedAnnual report
「The valuation difference on available-for-sale securities increased by ¥39 million.」
The valuation difference on available-for-sale securities increased by ¥39 million from the end of the previous consolidated fiscal year, with the valuation difference on held shares and other assets, which had declined significantly in the previous fiscal year, moving toward recovery during the current quarter. - FY2022MaterialisedAnnual report
「Total net assets decreased by ¥492 million from the end of the previous consolidated fiscal year to ¥9.01 billion. This was mainly due to a ¥468 million decrease in the valuation difference on available-for-sale securities.」
Changes in the fair value of held shares and other assets appeared as decreases of ¥468 million in the valuation difference on available-for-sale securities and ¥492 million in net assets. - FY2022-Q3MaterialisedAnnual report
「Total net assets decreased by ¥362 million from the end of the previous consolidated fiscal year to ¥9.14 billion. This was mainly due to decreases of ¥218 million in the valuation difference on available-for-sale securities and ¥149 million in retained earnings.」
The valuation difference on available-for-sale securities decreased by ¥218 million, with changes in the valuation of held shares and other assets appearing as an actual factor behind the decline in net assets. - FY2022-Q2MitigatedAnnual report
「Valuation difference on available-for-sale securities ¥1,375,056 ¥1,376,429」
The valuation difference on available-for-sale securities increased by ¥1.373 million from the end of the previous consolidated fiscal year, showing a modest increase after the decline seen in prior years. - FY2022-Q1MaterialisedAnnual report
「Total net assets decreased by ¥82 million from the end of the previous consolidated fiscal year to ¥9.42 billion. This was mainly due to an ¥81 million decrease in the valuation difference on available-for-sale securities.」
The valuation difference on held shares and other assets decreased by ¥81 million, appearing as an actual factor behind the decline in net assets. - FY2020MaterialisedAnnual report
「Special losses, including losses on valuation of investment securities, amounted to ¥57 million.」
In FY2020, the Company recognized a ¥51.944 million loss on valuation of investment securities, with the risk arising from declines in the fair value of held shares and deterioration in creditworthiness appearing as a valuation loss. - FY2020-Q3MaterialisedAnnual report
「Loss on valuation of investment securities - ¥413 thousand」
The Company recognized a ¥413 thousand loss on valuation of investment securities for the cumulative third quarter period, with the impairment risk from declines in the fair value of held shares and deterioration in creditworthiness appearing as a valuation loss. - FY2019RestatedAnnual report
「If impairment becomes necessary due to declines in fair value caused by deteriorating market conditions or deterioration in the creditworthiness of investees, business performance could be affected.」
The impairment risk arising from declines in the fair value of held shares and deterioration in the creditworthiness of investees remains ongoing. - FY2018RestatedAnnual report
「If impairment becomes necessary due to declines in fair value caused by deteriorating market conditions or deterioration in the creditworthiness of investees, business performance could be affected.」
The impairment risk arising from declines in the fair value of held shares and deterioration in the creditworthiness of investees remains ongoing. - FY2017RestatedAnnual report
「If impairment becomes necessary due to declines in fair value caused by deteriorating market conditions or deterioration in the creditworthiness of investees, business performance could be affected.」
The impairment risk arising from declines in the fair value of held shares and deterioration in the creditworthiness of investees remains ongoing. - FY2016First statedAnnual report
「If impairment becomes necessary due to declines in fair value caused by deteriorating market conditions or deterioration in the creditworthiness of investees, business performance could be affected.」
The disclosure identifies impairment risk from declines in fair value and deterioration in the creditworthiness of investees in relation to shareholdings held for business purposes.